Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/2005
09/22/2005US20050208011 Hair follicle growth
09/22/2005US20050205498 Preparation of a cell concentrate from a physiological solution
09/22/2005DE102004009985A1 Magnetische Manipulation von biologischen Proben Magnetic manipulation of biological samples
09/22/2005CA2581424A1 Methods for generating insulin-producing cells
09/22/2005CA2564614A1 Combinatorial interleukin-2 muteins
09/22/2005CA2560209A1 Tissue repair
09/22/2005CA2559585A1 Biological tissue sheet, method of forming the same and transplantation method by using the sheet
09/22/2005CA2559582A1 Corneal epithelial sheet, method of constructing the same and transplantation method using the sheet
09/22/2005CA2559550A1 Thiol methyltransferase-based selection
09/22/2005CA2559172A1 Therapeutic use of rm1 antigen
09/22/2005CA2559144A1 Estrogen receptor alpha splice variant er-.alpha.36
09/22/2005CA2559060A1 Phospholipases, nucleic acids encoding them and methods for making and using them
09/22/2005CA2558777A1 Regulatory t cells and their use in immunotherapy and suppression of autoimmune responses
09/22/2005CA2558641A1 Artificial mutation controls for diagnostic testing
09/22/2005CA2558632A1 Improved interleukin-2 muteins
09/22/2005CA2558486A1 Compositions and methods for growth of embryonic stem cells
09/22/2005CA2558025A1 Cell-penetrating socs polypeptides that inhibit cytokine-induced signaling
09/22/2005CA2557668A1 High efficiency peptide production in plant cells
09/22/2005CA2557374A1 Mutant proteins in the dna-binding domain of a trlomeric protein, trf2, and telomeric dna mutants, and use of the complex structure of the trf2 dna-binding domain and telomeric dna
09/21/2005EP1577391A1 Neutrokine alpha
09/21/2005EP1577381A1 Tumor/B-cell hybrid cells and uses thereof
09/21/2005EP1577380A1 Method of culturing pluripotent stem cells and culture apparatus therefor
09/21/2005EP1577379A1 Defined culture medium
09/21/2005EP1577083A1 Biodegradable substrate, prosthetic material for tissue regeneration and cultured tissue
09/21/2005EP1576957A1 Tissue repair using pluripotent cells
09/21/2005EP1576370A2 Methods of diagnosing and treating diabetes and insulin resistance
09/21/2005EP1576186A1 Method for generating a genetically modified organism for screening active substances
09/21/2005EP1576179A2 Methods and compositions for inducing apoptosis in cancer cells
09/21/2005EP1576175A2 Vascular-preferred promoters
09/21/2005EP1576169A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2005EP1576168A2 Therapeutic polypeptides nucleic acids encoding same and methods of use
09/21/2005EP1576149A1 Method for the separation of cell fractions
09/21/2005EP1576148A2 Process for coating cell-culture support
09/21/2005EP1576135A2 Method for regulating dopamine producing cells
09/21/2005EP1576134A2 Method for discovering neurogenic agents
09/21/2005EP1576131A2 Brain endothelial cell expression patterns
09/21/2005EP1576118A2 ALLELE-SPECIFIC siRNA-MEDIATED GENE SILENCING
09/21/2005EP1576117A2 Method of obtaining viable human liver cells, including hepatic stem/progenitor cells
09/21/2005EP1576110A2 Cell migration inhibiting compositions and methods and compositions for treating cancer
09/21/2005EP1576106A2 Process and materials for production of glucosamine and n-acetylglucosamine
09/21/2005EP1576102A2 Amidases, nucleic acids encoding them and methods for making and using them
09/21/2005EP1576101A2 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same
09/21/2005EP1576098A2 A human cell assay to determine effect of sample compounds on col2 enhancer expression
09/21/2005EP1576096A2 N-ACETYLGLUCOSAMINYLTRANSFERASE Vb CODING SEQUENCE, RECOMBINANT CELLS AND METHODS
09/21/2005EP1576091A2 Adult human olfactory stem cell
09/21/2005EP1576089A2 Expansion of renewable stem cell populations
09/21/2005EP1576088A2 Dominant negative proteins and methods thereof
09/21/2005EP1576087A2 Method for detecting remote homologues and kinases identified with the method
09/21/2005EP1576086A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2005EP1576013A2 Monoclonal antibody against interleukin-13 receptor alpha 1 (il-13ra1)
09/21/2005EP1576012A1 Monoclonal antibody against asialo alpha 1-acid glycoprotein, immunochromatographic strip comprising the monoclonal antibody, and method for diagnosing liver diseases using the immunochromatographic strip
09/21/2005EP1575998A2 Mammalian cell culture processes for protein production
09/21/2005EP1575984A2 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
09/21/2005EP1575917A2 Hemipteran muscarinic receptor
09/21/2005EP1575868A2 Nanotube mat with an array of conduits
09/21/2005EP1575658A2 Screening and therapeutic methods for treating circadian rhythm disorders
09/21/2005EP1575643A2 Directly injectable formulations which provide enhanced cryoprotection of cell products
09/21/2005EP1575572A2 Collagen biofabric and methods of preparation and use therefor
09/21/2005EP1575571A2 Compositions and methods for the diagnosis and treatment of tumor
09/21/2005EP1575524A2 Proliferated cell lines and uses thereof
09/21/2005EP1575509A2 Epha2 agonistic monoclonal antibodies and methods of use thereof
09/21/2005EP1575499A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
09/21/2005EP1575480A2 Compositions and methods for the treatment of immune related diseases
09/21/2005EP1534819A4 Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase
09/21/2005EP1326674B1 Microstructures for delivering a composition cutaneously to skin
09/21/2005EP1313870B1 Method for the improved production and isolation of trans-dihydroxycyclohexadiene carboxylic acids and/or derivatives thereof and a genetically modified organism suitable for the above
09/21/2005EP1263936B1 Altered strain of the modified vaccinia virus ankara (mva)
09/21/2005EP1212082A4 Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies
09/21/2005EP1192256B1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance
09/21/2005EP1129188B1 Pge synthase and methods and means for modulating its activity
09/21/2005EP1094081B1 Fused protein with direct bond of il-6-receptor to il-6
09/21/2005EP1061805B1 Regulation of endogenous gene expression in cells using zinc finger proteins
09/21/2005EP0994954B1 T7 promoter-based expression system
09/21/2005EP0974057B1 Methods to detect hk2 polypeptides
09/21/2005EP0846171B1 Chromosome 1 gene and gene products related to alzheimer's disease
09/21/2005EP0804565B1 Tetracycline-regulated transcriptional modulators
09/21/2005EP0792364B1 Lgmd gene coding for a calcium dependent protease
09/21/2005EP0776337B1 Growth differentiation factor-11
09/21/2005CN1672160A Generation and selection of protein library in silico
09/21/2005CN1672055A Heterologous stimulus-gated ion channels and methods of using same
09/21/2005CN1671860A Functional cardiomyocytes from human embryonic stem cells
09/21/2005CN1671851A Flavivirus vaccine delivery system
09/21/2005CN1671848A Method for enhancing yield of recombinant protein production from plants
09/21/2005CN1671845A Immunogenic sequences
09/21/2005CN1671843A Factor participating in transcriptional regulation
09/21/2005CN1671838A Genes from propionibacterium freudenreichii encoding enzymes involved in vitamin B12 biosynthesis
09/21/2005CN1671837A Neutralizing human anti-IGFR antibody
09/21/2005CN1671836A Primarily cultured adipocytes for gene therapy
09/21/2005CN1671835A A method for the establishment of a pluripotent human blastocyst-derived stem cell line
09/21/2005CN1671742A Use of HMGB1 in the treatment of tissue damage and/or to promote tissue repair
09/21/2005CN1671737A Export and modification of (poly)peptides in the lantibiotic way
09/21/2005CN1671733A Compositions and methods for WT1 specific immunotherapy
09/21/2005CN1671729A Control sequences of the human Corin gene
09/21/2005CN1671722A Campylobacter glycans and glycopeptides
09/21/2005CN1671426A Support for tissue regeneration and process for producing the same
09/21/2005CN1671425A ACE2 activation for treatment of heart, lung and kidney disease and hypertension
09/21/2005CN1671423A Novel chimeric CD154
09/21/2005CN1670213A Glyt1 transgenic mouse
09/21/2005CN1670208A Cancer-inhibiting gene and its application in preparing anticancer medicine combined with chemical therapeutic medicine
09/21/2005CN1670193A Vitrified freeze keeping liquid for biological tissue cell
1 ... 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 ... 1827